The historic decision authorizes full approval for adults aged 50 to 64 and grants accelerated approval for individuals aged 65 and older, contingent on post-marketing clinical studies. Traditional flu shots rely on egg- or cell-based manufacturing processes that require six to eight months to update each year. To provide our readers with timely and comprehensive coverage, South Florida Reporter uses artificial intelligence (AI) to assist in producing certain articles and visual content. General DisclaimerThe information contained in South Florida Reporter is for general information purposes only. South Florida Reporter assumes no responsibility for errors or omissions in the contents of the Service.